TransMedics Group, Inc. (TMDX)
Electromedical & Electrotherapeutic Apparatus · Healthcare · $2.6B
Intrinsic Value (Consensus)
$91.19
Current Price
$75.82
Margin of Safety
+20.3%
20.3% Below Intrinsic Value
Value: $91
Price: $76
Valuation Model Estimates
Current Price: $75.82
DCF (Discounted Cash Flow)
$181.34
Graham Number
$38.74
Earnings Power Value
$47.28
Relative Value (P/E)
$97.40
Dividend Discount Model
Not applicable
—
Consensus Value
$91.19
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
A
87
Profitability
25/25
Strength
24/25
Valuation
19/25
Growth
19/25
Financial Health Signals
Strong profitability — ROE of 40% (above 20% is excellent)
Low debt — conservative balance sheet
Strong earnings growth (20% YoY)
Key Financials
- EPS (TTM)
- $4.87
- EPS (Forward)
- $5.84
- Book Value
- $13.69
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 40.2%
- Debt/Equity
- 7%
- Revenue Growth
- 10.7%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance